Xtx Topco LTD Lava Therapeutics Nv Transaction History

Xtx Topco LTD

$1.81 Billion
Q1 2025

A detailed history of Xtx Topco LTD transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Xtx Topco LTD holds 24,307 shares of LVTX stock, worth $30,140. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,307

Holding current value

$30,140

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 07, 2025	BUY	$0.91 - $1.44 $22,119 - $35,002	24,307 New	24,307 $30,000
Q2 2024 Aug 12, 2024	BUY	$1.8 - $3.37 $55,452 - $103,819	30,807 New	30,807 $55,000

Others Institutions Holding LVTX

# of Institutions

Shares Held

4.93M

Call Options Held

50.2K

Put Options Held

200

Redmile Group, LLC San Francisco, CA

2.07M
Shares

$2.57 Million
0.28% of portfolio
Bml Capital Management, LLC Zionsville, IN

1.96M
Shares

$2.43 Million
2.02% of portfolio
Bruce & Co., Inc. Chicago, IL

522K
Shares

$647,123
0.28% of portfolio
Pathway Financial Advisors LLC

103K
Shares

$127,100
0.03% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

65K
Shares

$80,600
0.0% of portfolio

View Full List

About LAVA Therapeutics NV

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $32M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

More about LVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account